Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al.
Leonieke J J van MensMarleen G H van de SandeArno W R van KuijkDominique BaetenLaura C CoatesPublished in: Annals of the rheumatic diseases (2019)
Keyphrases